Estate Counselors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-6,900
Closed -$339K 66
2018
Q1
$339K Buy
+6,900
New +$354K 0.06% 64
2017
Q3
Sell
-12,900
Closed -$667K 59
2017
Q2
$667K Buy
12,900
+7,500
+139% +$379K 0.15% 52
2017
Q1
$272K Hold
5,400
0.07% 61
2016
Q4
$255K Hold
5,400
0.07% 67
2016
Q3
$269K Sell
5,400
-660
-11% -$33.5K 0.1% 51
2016
Q2
$292K Sell
6,060
-5,880
-49% -$280K 0.12% 53
2016
Q1
$545K Sell
11,940
-32,505
-73% -$1.52M 0.24% 42
2015
Q4
$2.4M Buy
44,445
+8,550
+24% +$450K 0.98% 27
2015
Q3
$1.76M Sell
35,895
-7,770
-18% -$445K 0.71% 33
2015
Q2
$2.54M Sell
43,665
-1,800
-4% -$105K 0.88% 29
2015
Q1
$2.61M Sell
45,465
-1,500
-3% -$82.1K 0.93% 29
2014
Q4
$2.37M Sell
46,965
-5,040
-10% -$246K 0.84% 30
2014
Q3
$2.43M Hold
52,005
0.94% 28
2014
Q2
$2.34M Sell
52,005
-3,450
-6% -$148K 0.89% 28
2014
Q1
$2.34M Sell
55,455
-240
-0.4% -$10.1K 0.94% 28
2013
Q4
$2.19M Hold
55,695
0.97% 28
2013
Q3
$1.98M Sell
55,695
-1,320
-2% -$46.5K 0.91% 28
2013
Q2
$1.91M Buy
+57,015
New +$1.89M 0.97% 27

Other funds holding IHE

Estate Counselors's IHE Position: Q2 2018 in Review

Estate Counselors sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2018, closing a stake of 6,900 shares — an estimated $339K sold.

Estate Counselors first reported a position in IHE in Q2 2013 and held it in 18 quarters. The position peaked at $2.61M in Q1 2015. 95 funds tracked by Wall St. Rank hold IHE as of Q2 2018.

  • Estate Counselors reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
  • Estate Counselors sold 6,900 iShares US Pharmaceuticals ETF shares in Q2 2018, an estimated $339K.
  • Estate Counselors first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 18 quarters.
  • Estate Counselors's iShares US Pharmaceuticals ETF position peaked at $2.61M in Q1 2015.
  • 95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2018.

Based on Estate Counselors's 13F filing for Q2 2018, filed 8 Aug 2018.